Alert Frequency, Nurse, and Patient Satisfaction With a wCVSM Software Across Health Care Systems and Cultures

Launched by CHRISTIAN S. MEYHOFF · Mar 1, 2024

Keywords

ClinConnect Summary

This clinical trial is exploring a new system for continuously monitoring vital signs, such as heart rate and breathing, in patients after surgery or during treatment for acute medical conditions. The study will involve 20 patients and 20 nurses at multiple hospitals around the world. Patients will have their vital signs checked with a special wireless monitoring system while also receiving standard care. Afterward, they will fill out a questionnaire about their experience. Nurses will also complete a questionnaire after caring for a monitored patient for a full shift. The main goals are to see how often alerts are triggered by the system, compare current monitoring practices, and assess how satisfied both patients and nurses are with the new technology.

To participate in this trial, individuals must be at least 18 years old and expected to stay in the hospital for at least two days. They should be admitted for surgery that lasts longer than two hours or for a serious medical condition that shows specific signs, such as a very high or low heart rate or breathing rate. However, people who have certain medical devices like pacemakers, or who cannot cooperate with the study, may not be eligible. If you take part, you can expect to help researchers understand how this new monitoring system works and how it can improve care for patients in the hospital.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adults (≥18 years)
• • Expected stay in the hospital ≥2 days
• • Admitted for surgery with expected duration of surgery \>2 hours or admitted for acute medical condition with at least one of the following vital sign deviations within 24 hours of acute admission, recorded by the staff
• • RR \> 21 breaths pr minute
• • RR \< 11 breaths pr minute
• • Pulse (P) \> 91 beats pr minute
• • Pulse (P) \< 50 beats pr minute
• • SpO2 \< 94 % without oxygen supplementation
• • Systolic BP \< 110 mmHg
• • Systolic BP \> 220 mmHg
• Exclusion Criteria:
• • Participant expected not to cooperate with study procedures.
• • Allergy to plaster or silicone.
• • Pacemaker or Implantable Cardioverter Defibrillator (ICD) device.
• • Inability to give informed consent.